|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Recent findings from multinational resistance surveys:are we ′PROTEKTed′ from resistance?显示文摘 | Marchese A Schito G C | 2007 | Int J Antimicrob Agents2007，29，1： | 1 |
| 2 | Barriers to physical activity in chronic hemodialysis patients: a single-center pilot study in an Italian dialysis facility 显示文摘 | Fiaccadori E Sabatino A Schito F et aI | 2014 | Kidney Blood Press Res2014，39，23： | 1 |
| 3 | Characterization of FOX-3,an AmpC-type plasmid-mediated-lactamase from an Italian isolate of klebsiella oxytoca显示文摘 | Marchese A Arler G Schito GC | 1998 | Antimicrob Agents Chemother1998，42，2： | 1 |
| 4 | Characterization of Fox3,an Amp C-type plasmid-mediated beta-lactamase from an Italian isolate of Klebsiella oxytoca显示文摘 | Marchese A Arlet G Schito GC | | 0，，02： | 1 |
| 5 | Characterization of FOX- 3,an AmpC- type plasmid- mediated beta- lactamase from an Italian isolate of Klebsiella oxytoca显示文摘 | Marchese A Arlet G Schito G C | 1998 | Antimicrob Agents Chemother1998，42，2： | 1 |
| 6 | Analysis of infraspecific variation among five strains of Eimeria maxima from North America显示文摘 | Barta J B Coles B A Schito M L | 1998 | Int J Parasitol1998，28，3： | 1 |
| 7 | Incidence of virulence determinants in clinical Enterococcus faecium and Enterococcus faecalis isolates collected inSardinia (Italy)显示文摘 | Dupre I Zanetti S Schito A M | 2003 | Med Microbiol2003，52，： | 1 |
| 8 | Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa 显示文摘 | Roveta S Schito A M Marchese A | 2005 | Int J Antimicrob Agents2005，26，： | 1 |
| 9 | Ballast flight under high-speed trains:Wind tunnel full-scale experimental tests显示文摘 | Premoli A Rocchi D Schito P | 2015 | Journal of Wind Engineering and Industrial Aerodynamics2015，145，： | 1 |
| 10 | In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance 显示文摘 | Gualco L Schito A M Schito G C | 2007 | Int J Antimicrob Agents2007，29，： | 1 |
| 11 | Comparative in vitro potency of gemifloxacin against European respiratory tract pathogens isolated in the Alexander Project显示文摘 | Marchese A Debbia EA Schito GC | 2000 | J Antimicrob Chemother2000，46，1： | 1 |
| 12 | In vitro assessment of the postantibiotic effect of lomefloxacin against gram -postive and gram -negative pathogens显示文摘 | Debbia E A Pesce A Schito G C | 1992 | Am J Med1992，92，4： | 1 |
| 13 | In vitro Assessment of the Postantibiotic Effect of Lomefloxacin against Gram-postive and Gram-negative Pathogens显示文摘 | Debbia E A Pesce A Schito G C | 1992 | Am J Med1992，92，4： | 1 |
| 14 | Incidence of virulencedeterminants in clinical Enterococcus faecium and Enterococcusfecalis isolates collected in Sardinia(Italy)显示文摘 | Dupre L Zanetti S Schito A M | 2003 | J MedMicrobiol2003，52，6： | 1 |
| 15 | Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseud ornonasaeruginosa 显示文摘 | Roveta S Schito A M Marchese A Schito G C | 2005 | Int J Antimicrob Agents2005，26，： | 1 |
| 16 | Activity ofmoxifloxacin on biofilms produced in vitro by bacterialpathogens involved in acute exacerbations of chronicbronchitis 显示文摘 | Roveta S Schito AM Marchese A | 2007 | Int J Antimicrob Agents2007，30，5： | 1 |
| 17 | Incidence of virulence determinants in clinical Entctococcus faecium and Enterococcus faecalis isolates collected in Sardinia (Italy) 显示文摘 | Dupre I Zanetti S Schito A M | 2003 | J Med Microbiol2003，52，6： | 1 |
| 18 | Analysis of infra-specific variation among five strains of Eimeria maxima from North America显示文摘 | Barta J B Coles B A Schito M L | 1998 | Int J Parasitol1998，28，3： | 1 |
| 19 | Targeted expression of SHH affects chondrocyte differentiation,growth plate organization,and Sox9 expression显示文摘 | Tavella S Biticchi R Schito A | 2004 | J Bone Miner Res2004，19，10： | 1 |
| 20 | Microbiological rationale for the utilisation of prulifloxacin,a new fluoroquinolone,in the eradication of serious infections caused by Pseudomonas aeruginosa显示文摘 | Roveta S Schito AM Marchese A | 2005 | Int J Antimicrob Agents2005，26，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员